Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02766985 · ClinicalTrials.gov registry record
Rasch-analysis of Clinical Severity in FSHD
A clinical trial, sponsored by University of Kansas Medical Center.
- Completed
- Registry status
- 44
- Enrollment target
NCT02766985: Completed study, sponsored by University of Kansas Medical Center.
NCT02766985 is a clinical trial that has completed, run by University of Kansas Medical Center. The registered enrollment target is 44 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02766985 has completed, sponsored by University of Kansas Medical Center.
- COMPLETED
- Registry status
- 44 participants
- Enrollment target
Study Summary
The purpose of this study is to make a standardized and scalable Rasch-built clinical severity scale to help in finding genetic and environmental modifiers of disease in Facioscapulohumeral muscular dystrophy (FSHD).
Primary Outcome
Measure severity of FSHD.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-04-18 |
What the finished NCT02766985 record still lists
NCT02766985 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 44 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02766985 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02766985 about?
NCT02766985 is a clinical study titled "Rasch-analysis of Clinical Severity in FSHD". The purpose of this study is to make a standardized and scalable Rasch-built clinical severity scale to help in finding genetic and environmental modifiers of disease in Facioscapulohumeral muscular dystrophy (FSHD).
What is the current status of trial NCT02766985?
This trial is currently completed. The enrollment target is 44 participants. The study started on 2016-03. Estimated completion is 2017-04-18.
Who is sponsoring clinical trial NCT02766985?
This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia